{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:43:08Z","timestamp":1770522188652,"version":"3.49.0"},"reference-count":45,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST 105-2311-B-039-003-MY2"],"award-info":[{"award-number":["MOST 105-2311-B-039-003-MY2"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST 107-2311-B-039-001-"],"award-info":[{"award-number":["MOST 107-2311-B-039-001-"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST 108-2311-B-039-001-"],"award-info":[{"award-number":["MOST 108-2311-B-039-001-"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST 109-2311-B-039-001"],"award-info":[{"award-number":["MOST 109-2311-B-039-001"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["CMU109-MF-102"],"award-info":[{"award-number":["CMU109-MF-102"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["CMU109-S-11"],"award-info":[{"award-number":["CMU109-S-11"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["CMU110-S-23"],"award-info":[{"award-number":["CMU110-S-23"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["CMU111-S-37"],"award-info":[{"award-number":["CMU111-S-37"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["CMU108-YTY-03"],"award-info":[{"award-number":["CMU108-YTY-03"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["MOST 105-2311-B-039-003-MY2"],"award-info":[{"award-number":["MOST 105-2311-B-039-003-MY2"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["MOST 107-2311-B-039-001-"],"award-info":[{"award-number":["MOST 107-2311-B-039-001-"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["MOST 108-2311-B-039-001-"],"award-info":[{"award-number":["MOST 108-2311-B-039-001-"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["MOST 109-2311-B-039-001"],"award-info":[{"award-number":["MOST 109-2311-B-039-001"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU109-MF-102"],"award-info":[{"award-number":["CMU109-MF-102"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU109-S-11"],"award-info":[{"award-number":["CMU109-S-11"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU110-S-23"],"award-info":[{"award-number":["CMU110-S-23"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU111-S-37"],"award-info":[{"award-number":["CMU111-S-37"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU108-YTY-03"],"award-info":[{"award-number":["CMU108-YTY-03"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Drug Development Center, China Medical University","award":["MOST 105-2311-B-039-003-MY2"],"award-info":[{"award-number":["MOST 105-2311-B-039-003-MY2"]}]},{"name":"Drug Development Center, China Medical University","award":["MOST 107-2311-B-039-001-"],"award-info":[{"award-number":["MOST 107-2311-B-039-001-"]}]},{"name":"Drug Development Center, China Medical University","award":["MOST 108-2311-B-039-001-"],"award-info":[{"award-number":["MOST 108-2311-B-039-001-"]}]},{"name":"Drug Development Center, China Medical University","award":["MOST 109-2311-B-039-001"],"award-info":[{"award-number":["MOST 109-2311-B-039-001"]}]},{"name":"Drug Development Center, China Medical University","award":["CMU109-MF-102"],"award-info":[{"award-number":["CMU109-MF-102"]}]},{"name":"Drug Development Center, China Medical University","award":["CMU109-S-11"],"award-info":[{"award-number":["CMU109-S-11"]}]},{"name":"Drug Development Center, China Medical University","award":["CMU110-S-23"],"award-info":[{"award-number":["CMU110-S-23"]}]},{"name":"Drug Development Center, China Medical University","award":["CMU111-S-37"],"award-info":[{"award-number":["CMU111-S-37"]}]},{"name":"Drug Development Center, China Medical University","award":["CMU108-YTY-03"],"award-info":[{"award-number":["CMU108-YTY-03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Drug combination therapy is a key approach in cancer treatments, aiming to improve therapeutic efficacy and overcome drug resistance. Evaluation of intracellular response in cancer cells to drug treatment may disclose the underlying mechanism of drug resistance. In this study, we aimed to investigate the effect of osimertinib, a tyrosine kinase inhibitor (TKI), and a curcumin derivative, 35d, on HCC827 cells and tumors by analyzing alterations in metabolome and related regulations. HCC827 tumor-bearing SCID mice and cultured HCC827 cells were separately examined. The treatment comprised four conditions: vehicle-only, 35d-only, osimertinib-only, and a combination of 35d and osimertinib. The treated tumors\/cells were subsequently subjected to metabolomics profiling, fatty acyl analysis, mitochondrial potential measurement, and cell viability assay. Osimertinib induced changes in the ratio of short-chain (SC) to long-chain (LC) fatty acyls, particularly acylcarnitines (ACs), in both tumors and cells. Furthermore, 35d enhanced this effect by further lowering the SC\/LC ratio of most ACs. Osimertinib and 35d also exerted detrimental effects on mitochondria through distinct mechanisms. Osimertinib upregulated the expression of carnitine palmitoyltransferase I (CPTI), while 35d induced the expression of heat shock protein 60 (HSP60). The alterations in ACs and CPTI were correlated with mitochondrial dysfunction and inhibited cell growth. Our results suggest that osimertinib and 35d disrupted the fatty acyl metabolism and induced mitochondrial stress in cancer cells. This study provides insights into the potential application of fatty acyl metabolism inhibitors, such as osimertinib or other TKIs, and mitochondrial stress inducers, such as curcumin derivatives, as combination therapy for cancer.<\/jats:p>","DOI":"10.3390\/ijms241512190","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T01:26:40Z","timestamp":1690766800000},"page":"12190","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Effects of a Curcumin Derivative and Osimertinib on Fatty Acyl Metabolism and Mitochondrial Functions in HCC827 Cells and Tumors"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7287-9278","authenticated-orcid":false,"given":"Min-Tsang","family":"Hsieh","sequence":"first","affiliation":[{"name":"Drug Development Center, China Medical University, Taichung 406040, Taiwan"},{"name":"School of Pharmacy, China Medical University, Taichung 406040, Taiwan"},{"name":"Chinese Medicinal Research and Development Center, China Medical University Hospital, Taichung 40447, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-4069","authenticated-orcid":false,"given":"Pei-Chih","family":"Lee","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biomedical Sciences, China Medical University, Taichung 406040, Taiwan"},{"name":"Research Center for Cancer Biology, China Medical University, Taichung 406040, Taiwan"},{"name":"Cancer Biology and Precision Therapeutics Center, China Medical University, Taichung 406040, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4614-4109","authenticated-orcid":false,"given":"Yi-Ting","family":"Chiang","sequence":"additional","affiliation":[{"name":"Drug Development Center, China Medical University, Taichung 406040, Taiwan"},{"name":"School of Pharmacy, China Medical University, Taichung 406040, Taiwan"},{"name":"Pharmacy Department, China Medical University Hsinchu Hospital, Hsinchu Country 302, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Yi","family":"Lin","sequence":"additional","affiliation":[{"name":"Drug Development Center, China Medical University, Taichung 406040, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3741-8753","authenticated-orcid":false,"given":"Der-Yen","family":"Lee","sequence":"additional","affiliation":[{"name":"Graduate Institute of Integrated Medicine, China Medical University, No. 91, Hsueh-Shih Road, Taichung 40402, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa0904554","article-title":"Screening for epidermal growth factor receptor mutations in lung cancer","volume":"361","author":"Rosell","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/JTO.0000000000000033","article-title":"A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)","volume":"9","author":"Shi","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.2147\/CMAR.S322967","article-title":"Efficacy and Prognosis of First-Line EGFR-Tyrosine Kinase Inhibitor Treatment in Older Adults Including Poor Performance Status Patients with EGFR-Mutated Non-Small-Cell Lung Cancer","volume":"13","author":"Chang","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"75ra26","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13045-016-0290-1","article-title":"EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancer","volume":"9","author":"Wang","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.bmcl.2016.02.067","article-title":"Recent progress on third generation covalent EGFR inhibitors","volume":"26","author":"Cheng","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-022-01313-4","article-title":"Mitochondrial adaptation in cancer drug resistance: Prevalence, mechanisms, and management","volume":"15","author":"Jin","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm.4399","article-title":"Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells","volume":"23","author":"Kuntz","year":"2017","journal-title":"Nat. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cmet.2017.09.009","article-title":"MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation","volume":"26","author":"Lee","year":"2017","journal-title":"Cell Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2012.11.020","article-title":"PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress","volume":"23","author":"Vazquez","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.leukres.2017.09.021","article-title":"Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia","volume":"62","author":"Henkenius","year":"2017","journal-title":"Leuk. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1007\/s00018-019-03134-0","article-title":"Drug repurposing to overcome resistance to various therapies for colorectal cancer","volume":"76","author":"Fong","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1038\/s41598-019-42357-w","article-title":"Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genes","volume":"9","author":"Marinello","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13058-019-1204-2","article-title":"Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51","volume":"21","author":"Lee","year":"2019","journal-title":"Breast Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/jcb.26291","article-title":"Metformin-induced alterations in nucleotide metabolism cause 5-fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinoma","volume":"119","author":"Mynhardt","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e192553","DOI":"10.1001\/jamaoncol.2019.2553","article-title":"Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial","volume":"5","author":"Arrieta","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2049-3002-2-4","article-title":"A strategically designed small molecule attacks alpha-ketoglutarate dehydrogenase in tumor cells through a redox process","volume":"2","author":"Stuart","year":"2014","journal-title":"Cancer Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1158\/1078-0432.CCR-14-1019","article-title":"A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies","volume":"20","author":"Pardee","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1158\/1078-0432.CCR-17-2282","article-title":"A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia","volume":"24","author":"Pardee","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Tomeh, M.A., Hadianamrei, R., and Zhao, X. (2019). A Review of Curcumin and Its Derivatives as Anticancer Agents. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20051033"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mbese, Z., Khwaza, V., and Aderibigbe, B.A. (2019). Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers. Molecules, 24.","DOI":"10.3390\/molecules24234386"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e202200485","DOI":"10.1002\/cbdv.202200485","article-title":"Recent Advances of Curcumin Derivatives in Breast Cancer","volume":"19","author":"Yin","year":"2022","journal-title":"Chem. Biodivers."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1039\/c9pp00375d","article-title":"Curcumin derivatives as photosensitizers in photodynamic therapy: Photophysical properties and in vitro studies with prostate cancer cells","volume":"19","author":"Kazantzis","year":"2020","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Baldassari, S., Balboni, A., Drava, G., Donghia, D., Canepa, P., Ailuno, G., and Caviglioli, G. (2023). Phytochemicals and Cancer Treatment: Cell-Derived and Biomimetic Vesicles as Promising Carriers. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15051445"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejmech.2017.03.006","article-title":"New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo","volume":"131","author":"Hsieh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_27","first-page":"67","article-title":"Effect of bis(hydroxymethyl) alkanoate curcuminoid derivative MTH-3 on cell cycle arrest, apoptotic and autophagic pathway in triple-negative breast adenocarcinoma MDA-MB-231 cells: An in vitro study","volume":"52","author":"Chang","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lee, D.Y., Hou, Y.C., Yang, J.S., Lin, H.Y., Chang, T.Y., Lee, K.H., Kuo, S.C., and Hsieh, M.T. (2020). Synthesis, Anticancer Activity, and Preliminary Pharmacokinetic Evaluation of 4,4-Disubstituted Curcuminoid 2,2-bis(Hydroxymethyl)Propionate Derivatives. Molecules, 25.","DOI":"10.3390\/molecules25030479"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.14348\/molcells.2020.0212","article-title":"Synthesis and Characterization of the Ethylene-Carbonate-Linked L-Valine Derivatives of 4,4-Dimethylcurcumin with Potential Anticancer Activities","volume":"26","author":"Lee","year":"2021","journal-title":"Molecules"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF03261931","article-title":"Carnitine and acylcarnitines: Pharmacokinetic, pharmacological and clinical aspects","volume":"51","author":"Reuter","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2165\/00003088-200342110-00002","article-title":"Pharmacokinetics of L-carnitine","volume":"42","author":"Evans","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"McCann, M.R., George De la Rosa, M.V., Rosania, G.R., and Stringer, K.A. (2021). L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine. Metabolites, 11.","DOI":"10.3390\/metabo11010051"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2125.2004.02194.x","article-title":"The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development","volume":"58","author":"Walker","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10937400306479","article-title":"Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment","volume":"6","author":"Dixit","year":"2003","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-022-01317-0","article-title":"The mitochondrial unfolded protein response (UPR(mt)): Shielding against toxicity to mitochondria in cancer","volume":"15","author":"Inigo","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Huang, Y.H., and Yeh, C.T. (2020). Functional Compartmentalization of HSP60-Survivin Interaction between Mitochondria and Cytosol in Cancer Cells. Cells, 9.","DOI":"10.3390\/cells9010023"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"101529","DOI":"10.1016\/j.molmet.2022.101529","article-title":"New dawn for cancer cell death: Emerging role of lipid metabolism","volume":"63","author":"Zhang","year":"2022","journal-title":"Mol. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"108256","DOI":"10.1016\/j.pharmthera.2022.108256","article-title":"Recent advances in metabolism and toxicity of tyrosine kinase inhibitors","volume":"237","author":"Zhao","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-021-03796-6","article-title":"Cycling cancer persister cells arise from lineages with distinct programs","volume":"596","author":"Oren","year":"2021","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/emboj\/18.8.2040","article-title":"Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells","volume":"18","author":"Samali","year":"1999","journal-title":"EMBO J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1074\/jbc.M603394200","article-title":"Heat shock protein 60 or 70 activates nitric-oxide synthase (NOS) I- and inhibits NOS II-associated signaling and depresses the mitochondrial apoptotic cascade during brain stem death","volume":"282","author":"Chan","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Jakic, B., Buszko, M., Cappellano, G., and Wick, G. (2017). Elevated sodium leads to the increased expression of HSP60 and induces apoptosis in HUVECs. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179383"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"31289","DOI":"10.1074\/jbc.M702777200","article-title":"Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: Evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase-3","volume":"282","author":"Chandra","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"101276","DOI":"10.1016\/j.molmet.2021.101276","article-title":"HSP60 reduction protects against diet-induced obesity by modulating energy metabolism in adipose tissue","volume":"53","author":"Hauffe","year":"2021","journal-title":"Mol. Metab."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/15\/12190\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:22:22Z","timestamp":1760127742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/15\/12190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":45,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["ijms241512190"],"URL":"https:\/\/doi.org\/10.3390\/ijms241512190","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,29]]}}}